Coronavirus Pandemics Era and Cancer Patients

Authors

  • Maria Tomás Microbiology Department-Research Institute Biomedical A Coruña (INIBIC), Hospital A Coruña (CHUAC), University of A Coruña (UDC), A Coruña, Spain. Spanish Society of Infectious Diseases and Clinical M2icrobiology (SEIMC). https://orcid.org/0000-0003-4501-0387

DOI:

https://doi.org/10.32635/2176-9745.RBC.2021v67n4.2430

Keywords:

Coronavirus, COVID-19, SARS-CoV-2, Pandemics, Neoplasms

Abstract

The SARS-CoV-2 virus and variants (Delta and Mu) will not be the last to provoke pandemics. To fight the new coronavirus species and SARS-CoV-2 variants, it will need to surge vaccination efforts, improve surveillance systems of animal reservoirs, use diagnostic efficiently and communicate consistently to health authorities. Cancer patients could develop new SARS-CoV-2 variants when full vaccination should be key to avoid such entanglement. The future of new pandemic around the world will depend on the development of the pan-coronavirus vaccines and the implementation of these measures across the globe.

Downloads

Download data is not yet available.

Downloads

Published

2021-11-24

How to Cite

1.
Tomás M. Coronavirus Pandemics Era and Cancer Patients. Rev. Bras. Cancerol. [Internet]. 2021 Nov. 24 [cited 2024 Jul. 3];67(4):e-252430. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/2430

Issue

Vol. 67 No. 4 (2021): Oct./Nov./Dec.

Section

OPINION

License

Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.